Saturday, June 15, 2024

Canopy and Flatiron Health Announce Partnership to Streamline Continuous Care Management for OncoEMR® Customers

Canopy, the first Continuous Care Platform for oncology, and Flatiron Health, a leading healthtech company dedicated to expanding the possibilities of point-of-care solutions in oncology, announced a partnership to streamline continuous care management for practices using Flatiron’s OncoEMR®.

Flatiron and Canopy share numerous customers, with triage teams using OncoEMR and Canopy side-by-side each day. Building on the longstanding collaboration between the companies, including recently announced FHIR® capabilities, this partnership aims to expand remote monitoring and triage management solutions to even more practices within Flatiron’s extensive network.

With Canopy, care teams remotely monitor patients using Electronic Patient-reported Outcomes (ePRO) tools while streamlining triage workflows with intelligent prioritization algorithms. Practices can also automatically capture reimbursement for this quality care through programs like Principal and Chronic Care Management (PCM/CCM).

Also Read: Athenahealth Launching New Suite of Tailored Specialty Solutions to Simplify the Practice of Healthcare in America

“Our collaboration with Flatiron Health has flourished, growing our shared provider base by 4X in 2023 and now exceeding 1,000 providers,” said Lavi Kwiatkowsky, Founder & CEO, Canopy. “We’re excited to build on these strong foundations, expand our partnership with Flatiron, and empower even more providers to offer continuous care between visits.”

“Through this collaboration between Flatiron Health and Canopy, we have an opportunity to not only support our provider networks and clinicians – but improve patient care and outcomes,” said Nina Chavez, VP of Strategic Partnerships and Alliances, Flatiron Health. “We’re thrilled to continue building on our relationship with Canopy and continue to execute against our mission to improve and extend lives by learning from the experience of every person with cancer.”

SOURCE: PRNewswire

Subscribe Now

    Hot Topics